International Journal of Epidemiology, Vol 18, S29-S37, Copyright © 1989 by International Epidemiological Association
S Bothig
The WHO MONICA Project is a multicentre international collaborative project
coordinated by the World Health Organization. Its objective is to measure
trends in cardiovascular mortality and morbidity and to assess the extent
to which these trends are related to changes in risk factor levels and/or
medical care, measured at the same time in defined communities in different
countries. Thirty-nine collaborating centres from 26 countries of Europe,
North America, and the Western Pacific collaborate in this project, using a
standardized protocol and covering a population of approximately 10 million
men and women aged 35-64. The WHO MONICA Project is directed by the Council
of Principal Investigators and a Steering Committee, and it is managed by a
Management Centre, Data Centre, Quality Control Centres (for event
registration, ECG coding and lipid determinations) and Reference Centres
(for optional studies). The MONICA methodology is increasingly used as a
measurement tool for cardiovascular and non-communicable diseases
prevention and control programmes by centres within and outside the
project.
ARTICLES
WHO MONICA Project: objectives and design
World Health Organization, Cardiovascular Diseases Unit, Geneva, Switzerland.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W.-Y. Huang, W.-H. Chow, N. Rothman, J. Lissowska, V. Llaca, M. Yeager, W. Zatonski, and R. B. Hayes Selected DNA repair polymorphisms and gastric cancer in Poland Carcinogenesis, August 1, 2005; 26(8): 1354 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Weidinger, N Klopp, S Wagenpfeil, L Rummler, M Schedel, M Kabesch, T Schafer, U Darsow, T Jakob, H Behrendt, et al. Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults J. Med. Genet., September 1, 2004; 41(9): 658 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Granger, R. J. Goldberg, O. Dabbous, K. S. Pieper, K. A. Eagle, C. P. Cannon, F. Van de Werf, A. Avezum, S. G. Goodman, M. D. Flather, et al. Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events Arch Intern Med, October 27, 2003; 163(19): 2345 - 2353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Eichner, S. T. Dunn, G. Perveen, D. M. Thompson, K. E. Stewart, and B. C. Stroehla Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review Am. J. Epidemiol., March 15, 2002; 155(6): 487 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Frohlich, M. Sund, B. Thorand, W. L. Hutchinson, M. B. Pepys, and W. Koenig Lack of Seasonal Variation in C-Reactive Protein Clin. Chem., March 1, 2002; 48(3): 575 - 577. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Burzotta, K. Paciaroni, V. De Stefano, P. Chiusolo, A. Manzoli, I. Casorelli, A.M. Leone, E. Rossi, G. Leone, A. Maseri, et al. Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease Eur. Heart J., January 1, 2002; 23(1): 26 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schunkert, U. Brockel, C. Hengstenberg, A. Luchner, M. W. Muscholl, K. Kurzidim, B. Kuch, A. Doring, G.u. A. J. Riegger, and H.-W. Hense Familial predisposition of left ventricular hypertrophy J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1685 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schunkert, H.-W. Hense, S. R. Holmer, M. Stender, S. Perz, U. Keil, B. H. Lorell, and G. Riegger Association between a Deletion Polymorphism of the Angiotensin-Converting-Enzyme Gene and Left Ventricular Hypertrophy N. Engl. J. Med., June 9, 1994; 330(23): 1634 - 1638. [Abstract] [Full Text]
|
|